News
Company news 
Pioneering European collaboration to advance genetic diagnostics: introducing the European Long Read Innovation Network (ELRIN)
Company news 
Oxford Nanopore Technologies and Dubai Health to collaborate on genetic screening
Company news 
Oxford Nanopore launches a comprehensive Hereditary Cancer Panel
Company news 
Oxford Nanopore launches a 24-hour whole genome sequencing workflow for rare disease research
Company news 
Oxford Nanopore expands Compatible Products Programme and strengthens multi-omics ecosystem
Company news 
Oxford Nanopore announces PromethION Plus Flow Cell and other human genetics updates at ASHG 2025
Company news 
Oxford Nanopore, Yemaachi Biotech, and Global Partners Collaborate to Improve Childhood Leukemia Outcomes in Ghana
Company news 
Oxford Nanopore announces landmark UK Government partnership to advance genomics-driven healthcare innovation in the UK | Oxford Nanopore Technologies
Company news 
Oxford Nanopore and UK Biobank to create world's first epigenetic dataset targeting the causes of cancer, dementia, complex disease | Oxford Nanopore Technologies
Company news 
Structural variation in human genomics: 6 things to read right now
Company news 
Oxford Nanopore Technologies announces new human health and disease study led by the UK National Institute for Health and Care Research (NIHR) BioResource
Technology 
Oxford Nanopore at ASHG 2021: find out how you can use nanopore technology to gain comprehensive, scalable, accurate insights in human genomics
Technology 
Oxford Nanopore announces multiple releases, for high-accuracy, content-rich, high-throughput whole-genome sequencing, and dynamic targeted sequencing
Community news 
"Most complete human genome assembly to date using single tech": Nature Biotech paper from consortium of nine centres use MinION to sequence human genome
Interviews 
Interview: Using PromethION for Cancer, Collaborations and more
Company news 
Interview: Scalable nanopore sequencing for Alzheimer’s research
Interviews 
Interview: The PromethION Experts at VIB
Interviews 
Interview: PromethION 24 and human disease research
Company news 
Interview: Exploring the potential of long-read whole-genome sequencing for identification of individuals with autism spectrum disorder
Interviews 
Interview: Exploring complex disease in Asian populations with PromethION